Literature DB >> 8307620

Localization of IFN-gamma and IL-6 mRNA in murine intestine by in situ hybridization.

S Bao1, S Goldstone, A J Husband.   

Abstract

Previous studies have highlighted the importance of CD4+ T cells in regulation of IgA responses and have indicated a functional heterogeneity among these cells between inductive (Peyer's patch) and effector (lamina propria) sites in the intestine. To determine whether these functional differences could be accounted for by differences in cytokine profile of cells in each of these sites, the distribution of mRNA for interferon-gamma (IFN-gamma) and interleukin-6 (IL-6) was investigated by in situ hybridization techniques using 35S-labelled riboprobes. Whereas message for IL-6 is abundant in all regions of the lamina propria from the base of the mucosa to the tips of the villi, very little is expressed in Peyer's patches or in the epithelium. In contrast, message for IFN-gamma is expressed predominantly by cells localized only in the base of the lamina propria and, as with IL-6, very little message was detected in Peyer's patches although occasional strongly positive IFN-gamma cells were observed in the epithelium. These results indicate that, at least in the absence of deliberate intestinal stimulation, functional expression of these cytokines is restricted to effector rather than induction sites in the intestine. This is consistent with our previous observations demonstrating a requirement for T-cell signals in promoting post-extravasation differentiation and proliferation of IgA-committed B cells in vivo and the implications of these findings to the role of the Th1 and Th2 subsets of CD4+ cells in mucosal immune responses is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8307620      PMCID: PMC1422253     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

1.  Comparative mapping of the local distribution of immunoglobulin-containing cells in ulcerative colitis and Crohn's disease of the colon.

Authors:  K Baklien; P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1975-11       Impact factor: 4.330

Review 2.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

3.  Murine T-cell clones specific for chicken erythrocyte alloantigens.

Authors:  M A Giedlin; B M Longenecker; T R Mosmann
Journal:  Cell Immunol       Date:  1986-02       Impact factor: 4.868

4.  IL-1 stimulates IL-6 production in endothelial cells.

Authors:  M Sironi; F Breviario; P Proserpio; A Biondi; A Vecchi; J Van Damme; E Dejana; A Mantovani
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

Review 5.  The role of IL4 and IL5: characterization of a distinct helper T cell subset that makes IL4 and IL5 (Th2) and requires priming before induction of lymphokine secretion.

Authors:  S L Swain; D T McKenzie; R W Dutton; S L Tonkonogy; M English
Journal:  Immunol Rev       Date:  1988-02       Impact factor: 12.988

6.  Interleukin 5 and interleukin 4 produced by Peyer's patch T cells selectively enhance immunoglobulin A expression.

Authors:  P D Murray; D T McKenzie; S L Swain; M F Kagnoff
Journal:  J Immunol       Date:  1987-10-15       Impact factor: 5.422

7.  Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones.

Authors:  D J Cher; T R Mosmann
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

8.  Mucosal cell proliferation in duodenal ulcer and duodenitis.

Authors:  C J Bransom; M E Boxer; K R Palmer; J C Clark; J C Underwood; H L Duthie
Journal:  Gut       Date:  1981-04       Impact factor: 23.059

9.  Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells.

Authors:  K W Beagley; J H Eldridge; F Lee; H Kiyono; M P Everson; W J Koopman; T Hirano; T Kishimoto; J R McGhee
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

10.  The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells.

Authors:  A Muraguchi; T Hirano; B Tang; T Matsuda; Y Horii; K Nakajima; T Kishimoto
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

View more
  7 in total

1.  Effects of type I/type II interferons and transforming growth factor-beta on B-cell differentiation and proliferation. Definition of costimulation and cytokine requirements for immunoglobulin synthesis and expression.

Authors:  D M Estes; W Tuo; W C Brown; J Goin
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

2.  Professor Cristobal G dos Remedios mentorship.

Authors:  Shisan Bob Bao
Journal:  Biophys Rev       Date:  2020-07-13

3.  Interferon-gamma receptor-deficient mice exhibit impaired gut mucosal immune responses but intact oral tolerance.

Authors:  M Kjerrulf; D Grdic; L Ekman; K Schön; M Vajdy; N Y Lycke
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

4.  Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6.

Authors:  R Daig; G Rogler; E Aschenbrenner; D Vogl; W Falk; V Gross; J Schölmerich; T Andus
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

Review 5.  Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation?

Authors:  W L Biffl; E E Moore; F A Moore; V M Peterson
Journal:  Ann Surg       Date:  1996-11       Impact factor: 12.969

6.  Synthesis and regulation of accessory/proinflammatory cytokines by intestinal epithelial cells.

Authors:  A Panja; E Siden; L Mayer
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

7.  The Effects of Exercise on Plaque Volume and Composition in a Mouse Model of Early and Late Life Atherosclerosis.

Authors:  Kelly M Stanton; Hongjuan Liu; Vivian Kienzle; Christina Bursill; Shisan Bao; David S Celermajer
Journal:  Front Cardiovasc Med       Date:  2022-03-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.